AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GOSERELINE
9 registrations across 4 African markets— 6 active
Markets with GOSERELINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ZOLADEX 10,8MG IMPLANT EB SERINGUE PREREMPLIE POUR VOIE SOUS-CUTANEE+SYSTEME DE SECURITE BOITE DE 1 | 🇨🇮Côte d'Ivoire | ASTRAZENECA | active | Aug 2027 |
| ZOLADEX 3,6MG IMPLANT EN SERINGUE PREREMPLIE EN SC BOITE DE 1 | 🇨🇮Côte d'Ivoire | ASTRAZENECA | active | Aug 2026 |
| GOSERELIN-CIMEX Implant / 3.6 mg | 🇹🇳Tunisia | ACINO pharma AG | expired | May 2013 |
| ZOLADEX Implant / 10.8 MG | 🇹🇳Tunisia | ASTRA ZENECA | expired | Feb 1999 |
| ZOLADEX Implant / 3.6 MG | 🇹🇳Tunisia | ASTRA ZENECA | expired | May 1992 |
| ZOLADEX implant en seringue pré remplie / 3,6 mg | 🇸🇳Senegal | ASTRA ZENECA | active | — |
| ZOLADEX implant en seringue pré remplie / 10,8 mg | 🇸🇳Senegal | ASTRA ZENECA | active | — |
| ZOLADEX 10.8 MG IMPLANT INJECTABLE | 🇲🇦Morocco | — | active | — |
| ZOLADEX 3.6 MG IMPLANT INJECTABLE | 🇲🇦Morocco | — | active | — |
GOSERELINE in Africa — Regulatory Overview
GOSERELINE is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Côte d'Ivoire, Morocco, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.